What is the lorazepam (Ativan) dose equivalent to clonazepam 1 mg taken three times daily?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 1, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Benzodiazepine Dose Conversion: Clonazepam to Lorazepam

Clonazepam 1 mg three times daily (3 mg/day total) converts to approximately lorazepam 1.5 mg three times daily (4.5 mg/day total), using a 2:3 potency ratio where clonazepam is roughly 1.5-2 times more potent than lorazepam.

Conversion Rationale

The conversion between these benzodiazepines is based on established relative potencies, though no direct guideline explicitly addresses this specific adult outpatient conversion. The pediatric neonatal withdrawal guideline 1 provides the only formal conversion framework, stating that lorazepam is twice as potent as midazolam. While this doesn't directly address clonazepam-to-lorazepam conversion, clinical pharmacology establishes that:

  • Clonazepam is approximately 1.5-2 times more potent than lorazepam based on receptor binding affinity and clinical dosing patterns
  • Using a conservative 2:3 ratio (clonazepam:lorazepam), multiply the clonazepam dose by 1.5

Calculation:

  • Current dose: Clonazepam 1 mg TID = 3 mg/day
  • Conversion: 3 mg × 1.5 = 4.5 mg lorazepam/day
  • Divided dosing: 1.5 mg lorazepam three times daily

Critical Considerations for Safe Conversion

Half-Life Differences Matter

Clonazepam has a significantly longer half-life (18-50 hours) compared to lorazepam (10-20 hours) 2. This means:

  • Start with the calculated equivalent dose but monitor closely for the first 3-5 days as clonazepam clears from the system
  • Patients may experience breakthrough symptoms between lorazepam doses due to shorter duration of action
  • Consider giving a slightly higher bedtime dose (e.g., 1 mg-1.5 mg-2 mg dosing pattern) to maintain overnight coverage

Withdrawal Risk

The 2012 pediatric guideline 1 emphasizes that "signs and symptoms of withdrawal from benzodiazepine therapy can be delayed" and recommends weaning by 10-20% per day when discontinuing. For conversion:

  • Do NOT abruptly stop clonazepam and start lorazepam
  • Use a brief overlap period: Start lorazepam at full calculated dose while tapering clonazepam by 50% for 2-3 days, then discontinue clonazepam
  • This prevents withdrawal symptoms while establishing therapeutic lorazepam levels

Dosing Frequency Adjustment

Given lorazepam's shorter half-life, some patients may require four times daily dosing (every 6 hours) rather than three times daily for equivalent symptom control, particularly if treating anxiety or panic disorder. The FDA label 3 supports dosing intervals as frequent as every 6-8 hours.

Alternative Approach: Start Lower and Titrate

Given the serious risk of oversedation when converting between benzodiazepines, a safer clinical approach is:

  1. Start with lorazepam 1 mg TID (3 mg/day total - slightly lower than calculated equivalent)
  2. Overlap with reduced clonazepam (0.5 mg TID) for 48-72 hours
  3. Discontinue clonazepam and assess response
  4. Titrate lorazepam up to 1.5 mg TID if needed based on symptom control over the next week

Common Pitfalls to Avoid

  • Do not use a 1:1 conversion ratio - this significantly underdoses and risks breakthrough symptoms or withdrawal
  • Do not ignore the indication - if converting for panic disorder, the FDA label 4 notes clonazepam's optimal dose is 1 mg/day, suggesting the original 3 mg/day may already be higher than necessary
  • Monitor for respiratory depression - the 2018 ESMO guideline 5 warns about combining benzodiazepines with other CNS depressants, and the 2025 geriatric study 6 found benzodiazepines, particularly midazolam, had the worst safety profile with increased respiratory events
  • Assess for hepatic impairment - lorazepam clearance is less affected by liver disease than other benzodiazepines 3, but dose reduction may still be needed

Duration of Action Advantage

Research demonstrates that lorazepam has a longer duration of anticonvulsant action (up to 72 hours) compared to clonazepam's 24 hours in acute settings 2, though this applies primarily to single-dose scenarios rather than chronic dosing. For chronic anxiety or seizure management, the practical difference is lorazepam's shorter elimination half-life requiring more frequent dosing or acceptance of fluctuating blood levels.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.